Drug recall · January 31, 2024
Fosaprepitant for Injection 150 mg per vial recall
Why: Lack of Sterility Assurance: Aseptic process simulation failure.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.
- Lots / codes
lot #13D012AA, Exp: 08/31/2025
- Quantity
- 22,176 Vials
- Company
- Be Pharmaceuticals AG, Zug, N/A
- Distribution
- Nationwide in the USA
- Initiated
- January 10, 2024 · Voluntary: Firm initiated
- Classified
- January 25, 2024
- Reported
- January 31, 2024
- Ended
- June 10, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fosaprepitant
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.